CMS explains what went into its first round of drug price negotiations

Zachary Brennan

Senior Editor

Nicole DeFeudis

Editor

The Centers for Medicare and Medicaid Services on Friday released detailed but heavily redacted explanations of how it determined new prices for the first 10 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

CMS explains what went into its first round of drug price negotiations

Zachary Brennan

Senior Editor

Nicole DeFeudis

Editor

Sign up to read this article for free.

Three drugmakers sue US over 340B discounts to STD clinics they allege don’t qualify

Deerfield wins fight to acquire Singular Genomics, beating out Tang Capital’s Concentra

FDA approves Lilly's Zepbound for sleep apnea, likely cracking open Medicare market

CagriSema’s weight loss data disappointed. What does Novo do next?

Vertex gets 'vanza triple' approval and Trikafta expansion — with boxed warnings

Viatris' India-based manufacturing site blocked from shipping 11 generic drugs to US

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Senior Editor

Editor

Sign up to read this article for free.

more like this

CMS explains what went into its first round of drug price negotiations